How Long is Wegovy Good For? Understanding Its Efficacy and Duration

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works as long as you continue taking it—clinical trials show sustained weight loss over 68 weeks when doses are optimized for your body. Understanding how semaglutide's duration translates to real-world results helps you plan realistic expectations and long-term management strategies.

How Long Does Semaglutide Stay Active in Your System?

Semaglutide has a half-life of about 7 days, meaning the drug concentration in your bloodstream reduces by half each week. Weekly injections maintain therapeutic levels because each dose builds on the previous one, creating stable appetite suppression. This extended half-life is why once-weekly dosing works effectively for weight management.

After you stop taking semaglutide, it typically clears from your system within 4 to 5 weeks. During this washout period, appetite and blood sugar regulation gradually return to baseline. Some people maintain weight loss momentum for a short time after stopping, but most experience appetite return and weight regain beginning in the first few weeks.

Duration of Weight Loss Results on Semaglutide

Clinical evidence shows that semaglutide produces meaningful weight loss when doses are titrated properly over 16 to 20 weeks. The STEP trials demonstrated that participants using semaglutide achieved 10% to 15% body weight reduction by week 68, with weight stabilizing at those lower levels as long as treatment continued. Results vary based on starting weight, adherence, and individual metabolic response.

Weight loss typically follows a predictable curve: rapid initial loss in months 1 to 4, plateau around weeks 12 to 16, then gradual continued loss through month 6. Many patients see the greatest reductions in the first 12 weeks, after which the rate of loss slows but continues. This plateau reflects the body reaching a new equilibrium at lower appetite signaling.

What Happens to Weight When You Stop Semaglutide?

Research shows that weight regain begins within the first month after stopping semaglutide, with most people regaining 50% of lost weight within one year. One large clinical trial found that discontinuing semaglutide led to progressive appetite return and body weight increase that mirrored the trajectory during initial weight loss. This pattern suggests semaglutide addresses a chronic appetite dysregulation that persists when treatment stops.

Long-term weight maintenance after semaglutide requires either resuming treatment or adopting sustained lifestyle modifications that were difficult to maintain before. Some patients find that semaglutide use creates a therapeutic window where behavioral changes feel easier, allowing them to establish new habits. For many, continuous or intermittent dosing becomes the realistic approach to prevent weight rebound.

Personalized Dosing Extends Semaglutide Efficacy

PlexusDx compounds semaglutide injections at starting doses of $189 per month, with titration schedules tailored to your metabolic profile and tolerance. Dose escalation follows standard protocols—typically increasing every 4 weeks—but individual responses determine optimal maintenance levels. Personalized dosing means your price remains flat even as your clinical dose increases, following the principle that your dose may need to go up, but your price won't.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long do I need to take semaglutide to see weight loss results?

Most patients notice appetite reduction within days, but measurable weight loss typically appears within 4 to 6 weeks of consistent dosing. Significant results—5% to 10% body weight loss—usually occur by week 16 when doses are optimized. PlexusDx compounded semaglutide allows flexible dosing adjustments every month to match your response timeline.

Will semaglutide work forever, or does my body develop tolerance?

Clinical evidence does not show tolerance development over one to two years of continuous use; weight loss remains sustained at optimized doses. However, some individuals report needing minor dose adjustments over time as metabolism adapts. Long-term studies beyond 2 years remain limited, making ongoing medical supervision important for extended treatment.

Can I take semaglutide short-term and keep the weight off?

Short-term use (under 6 months) typically results in weight regain once stopped, with most people recovering 50% of lost weight within one year. Semaglutide works best as a long-term management strategy rather than a short-term intervention. PlexusDx offers flexible month-to-month enrollment without membership fees, letting you continue treatment as long as clinically appropriate.

What's the difference between compounded semaglutide and brand-name Wegovy?

Compounded semaglutide from PlexusDx's licensed 503A pharmacies contains the same active ingredient as Wegovy at a lower cost ($189/month vs. $300+ for branded). Both deliver identical pharmacology and timeline to results; the difference is price accessibility and no insurance requirement. Compounded semaglutide is not FDA-approved as a finished product, but the ingredient and compounding standards meet pharmaceutical quality requirements.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (FTO and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy
• Hims Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.